| Quarter (USD) | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 70.97 mm | 70.97 mm | 70.97 mm | 70.97 mm | 70.97 mm | 70.97 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 7.33 mm | 7.74 mm | 4.42 mm | 5.39 mm |
| Cash used (since last report) | n/a | n/a | 359.05 mm | 379.21 mm | 216.67 mm | 264.00 mm |
| Cash remaining | n/a | n/a | -288.08 mm | -308.25 mm | -145.71 mm | -193.03 mm |
| Runway (months of cash) | n/a | n/a | -39.3 | -39.8 | -33.0 | -35.8 |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 240.87 mm |
| Total shares | 6.34 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Biotechnology Value Fund L P | 6.34 mm | $240.87 mm |
